Asia Pacific Addictions Therapeutics Market Forecast to 2027 - By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Asia Pacific Addictions Therapeutics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Asia Pacific Addictions Therapeutics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising prevalence of addiction disorders
5.1.2 Increased focus on mental health
5.1.3 Growth in personalized therapies

5.2 Market Opportunities

5.2.1 Innovative treatment methods emerging
5.2.2 Increasing awareness on addiction care
5.2.3 Government initiatives for addiction care

5.3 Future Trends

5.3.1 Personalized addiction treatment focus
5.3.2 Expansion of digital therapy solutions
5.3.3 Increased telemedicine applications

5.4 Impact of Drivers and Restraints

6. Asia Pacific Addictions Therapeutics Market Regional Analysis

6.1 Asia Pacific Addictions Therapeutics Market Overview

6.2 Asia Pacific Addictions Therapeutics Market Revenue 2017-2027 (US$ Million)

6.3 Asia Pacific Addictions Therapeutics Market Forecast Analysis

7. Asia Pacific Addictions Therapeutics Market Analysis – by Treatment Type

7.1 Nicotine Addiction Treatment

7.1.1 Overview
7.1.2 Nicotine Addiction Treatment: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Alcohol Addiction Treatment

7.2.1 Overview
7.2.2 Alcohol Addiction Treatment: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Opioid Addiction Treatment

7.3.1 Overview
7.3.2 Opioid Addiction Treatment: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Other Substance Addiction Treatment

7.4.1 Overview
7.4.2 Other Substance Addiction Treatment: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Addictions Therapeutics Market Analysis – by Drug Type

8.1 Varenicline

8.1.1 Overview
8.1.2 Varenicline: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Bupropion

8.2.1 Overview
8.2.2 Bupropion: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Nicotine Replacement Products

8.3.1 Overview
8.3.2 Nicotine Replacement Products: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Buprenorphine

8.4.1 Overview
8.4.2 Buprenorphine: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.5 Naltrexone

8.5.1 Overview
8.5.2 Naltrexone: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.6 Disulfiram

8.6.1 Overview
8.6.2 Disulfiram: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9. Asia Pacific Addictions Therapeutics Market Analysis – by Treatment Center

9.1 Outpatient Treatment Center

9.1.1 Overview
9.1.2 Disulfiram: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Residential Treatment Center

9.2.1 Overview
9.2.2 Disulfiram: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.3 Inpatient Treatment Center

9.3.1 Overview
9.3.2 Disulfiram: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

10. Asia Pacific Addictions Therapeutics Market – Asia-Pacific Analysis

10.1 Asia-Pacific

10.1.1 Asia Pacific Addictions Therapeutics Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 Asia Pacific Addictions Therapeutics Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 China: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Type
10.1.1.1.2 China: Asia Pacific Addictions Therapeutics Market Breakdown, by Drug Type
10.1.1.1.3 China: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Center

10.1.1.2 India: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 India: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Type
10.1.1.2.2 India: Asia Pacific Addictions Therapeutics Market Breakdown, by Drug Type
10.1.1.2.3 India: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Center

10.1.1.3 Japan: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 Japan: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Type
10.1.1.3.2 Japan: Asia Pacific Addictions Therapeutics Market Breakdown, by Drug Type
10.1.1.3.3 Japan: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Center

10.1.1.4 Australia: Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.4.1 Australia: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Type
10.1.1.4.2 Australia: Asia Pacific Addictions Therapeutics Market Breakdown, by Drug Type
10.1.1.4.3 Australia: Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Center

10.1.1.5 Rest of Asia-Pacific : Asia Pacific Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Type
10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Addictions Therapeutics Market Breakdown, by Drug Type
10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Addictions Therapeutics Market Breakdown, by Treatment Center

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Asia Pacific Addictions Therapeutics Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Indivior PLC

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 GlaxoSmithKline plc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Bausch Health Companies Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Cipla Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Alvogen

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Camurus AB

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Hikma Pharmaceuticals PLC

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights